Fresenius medical care announces fda clearance of versi®hd with guideme software

Waltham, mass. , aug. 23, 2023 /prnewswire/ -- fresenius medical care, the world's leading provider of products and services for individuals with renal diseases, today announced the u.s. food and drug administration (fda) 510(k) clearance for versi®hd with guideme software, a completely reinvented self-guided interface for the company's versihd chronic home hemodialysis (hhd) system.
FMS Ratings Summary
FMS Quant Ranking